|
|
|
40
|
5281BB
|
MOXICIP 0.5% EYE DR (CIP/AHI) MOXIFLOXACIN
|
MOXIFLOXACIN
|
MOXICIP
|
5ML
|
BQ
|
10.60
|
10.60
|
EYE DROP
|
0
|
BOTT
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2022-09-30
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
2022-03-29
|
|
|
|
40
|
5281BX
|
OPTIMOX 0.5% EYE DR (ARP/AHI) MOXIFLOXACIN
|
MOXIFLOXACIN
|
OPTIMOX
|
5ML
|
BQ
|
8.70
|
8.70
|
EYE DROP
|
0
|
BOTT
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
5281CD
|
VIGAMOX 0.5% EYE DR (NVS/COL) MOXIFLOXACIN
|
MOXIFLOXACIN
|
VIGAMOX
|
3ML
|
C
|
27.05
|
27.05
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
5281CE
|
VIGAMOX 0.5% EYE DR (NVS) MOXIFLOXACIN (C)
|
MOXIFLOXACIN
|
VIGAMOX
|
5ML
|
C
|
45.4
|
45.396
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281CE
|
VIGAMOX 0.5% EYE DR (NVS) MOXIFLOXACIN
|
MOXIFLOXACIN
|
VIGAMOX
|
5ML
|
C
|
45.40
|
45.40
|
BOTT
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
5281CF
|
ENMOX 0.5% EYE DR (SHC) MOXIFLOXACIN (BQ)
|
MOXIFLOXACIN
|
ENMOX
|
5ML
|
BQ
|
5.71
|
5.7085
|
BOTT
|
0
|
BOTT
|
SHC
|
SION HEALTHCARE
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
42
|
5281CR
|
4QUIN 0.5% EYE DR (ADO) MOXIFLOXACIN
|
MOXIFLOXACIN
|
4 QUIN
|
5ML
|
BQ
|
6.25
|
6.25
|
BOTT
|
0
|
BOTT
|
ADO
|
ADORE PHARMA
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
520404
|
EENT ANTIBACTERIALS
|
2026-04-01
|
|
|
OPHTHALMIC
|
0
|
EENT ANTIBACTERIALS
|
|
|
|
|
41
|
6451AE
|
4-QUIN D 0.1%|0.5% EYE DR (HAN) DEXAMETHASONE|MOXIFLOXACIN (BQ)
|
DEXAMETHASONE|MOXIFLOXACIN
|
4-QUIN D
|
5ML
|
BQ
|
3.94
|
3.9416
|
BOTT
|
1
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6451Z
|
VIGADEXA 0.1% | 0.5% EYE DR (NVS/COL) DEXAMETHA
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
BQ
|
20.39
|
20.39
|
EYE DROP
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6451Z
|
VIGADEXA 0.1%|0.5% EYE DR (NVS) DEXAMETHASONE|MOXIFLOXACIN (C)
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
C
|
20.39
|
20.3874
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6451Z
|
VIGADEXA 0.1%|0.5% EYE DR (NVS) DEXAMETHASONE|MOXIFLOXACIN
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
C
|
20.39
|
20.39
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6711AL
|
AVELOX 400MG TAB (BSP/COL) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
20'S
|
C
|
182.13
|
9.11
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
6711AL
|
AVELOX 400MG TAB (BSP) MOXIFLOXACIN (C)
|
MOXIFLOXACIN
|
AVELOX
|
20'S
|
C
|
182.13
|
9.1064
|
TAB
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711DD
|
AVELOX 400MG TAB (BSP) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
5'S
|
C
|
45.53
|
9.11
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
40
|
6711EK
|
AVELOX 400MG TAB (BSP/AHI) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
20'S
|
C
|
182.13
|
9.11
|
TABLET
|
0
|
TAB
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
6711EK
|
AVELOX 400MG TAB (BSP) MOXIFLOXACIN (C)
|
MOXIFLOXACIN
|
AVELOX
|
20'S
|
C
|
182.13
|
9.1064
|
TAB
|
0
|
BOX
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711EK
|
AVELOX 400MG TAB (BSP) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
20'S
|
C
|
120.29
|
6.01
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
41
|
6711KV
|
OXIFLED 400MG TAB (MSN) MOXIFLOXACIN (C)
|
MOXIFLOXACIN
|
OXIFLED
|
10'S
|
C
|
7.96
|
0.7965
|
TAB
|
0
|
BOTT
|
MSN
|
MSN LABS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
081218
|
QUINOLONES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
42
|
6711ME
|
AVELOX 400MG TAB (BSP) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
5'S
|
C
|
41.43
|
8.29
|
TAB
|
0
|
BLIS
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
AVENTA BARBADOS
|
|
081218
|
QUINOLONES
|
2026-04-01
|
|
|
ORAL
|
0
|
QUINOLONES
|
|
|
|
|
40
|
6712C
|
AVELOX 400MG INJ (BSP/COL) MOXIFLOXACIN
|
MOXIFLOXACIN
|
AVELOX
|
250ML
|
C
|
50.70
|
50.70
|
INJECTION
|
0
|
VIAL
|
BSP
|
BAYER SCHERING PHARMA AG.
|
COL
|
COLLINS LTD
|
|
081218
|
QUINOLONES
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
